Semaglutide's Cardiac Safety: No QTc Prolongation in Healthy Subjects
A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects
Background
Cardiac repolarisation, the process where heart muscle cells reset after each beat, is crucial for normal heart function. Disruptions, often measured by the QTc interval on an electrocardiogram (ECG), can lead to serious ventricular arrhythmias (irregular heartbeats) and sudden cardiac death. Many new drugs are required to undergo a Thorough QTc (TQT) study to ensure they do not prolong this interval. This study specifically aimed to thoroughly evaluate if semaglutide, a widely used GLP-1 receptor agonist, affects cardiac repolarisation in healthy individuals.
Study Design
Population
Healthy subjects (n not specified) undergoing cardiac repolarisation assessment.
Intervention
Semaglutide (dose, route, duration not specified in digest).
Outcome
The primary outcome was the effect of semaglutide on cardiac repolarisation, specifically measured by the QTc interval on an electrocardiogram.